At AstraZeneca, we believe it’s not enough for us to simply make medicines. We have to help make sure that the people who need those medicines have access to them. It’s why we’ve offered patient assistance programs for more than 35 years.
Programs Offered
Therapies Offered
-
ARIMIDEX® (anastrozole) Tablets
-
BRILINTA® (ticagrelor) 90mg Tablets
-
BYDUREON® (exenatide extended-release) for injectable suspension
-
BYETTA® (exenatide) Injection
-
CRESTOR® (rosuvastatin calcium) Tablets
-
Daliresp® (roflumilast) tablets 500mcg
-
FARXIGA® (dapagliflozin) Tablets
-
FASLODEX® (fulvestrant) Injection
-
Iressa® (gefitnib) tablets 350mg
-
KOMBIGLYZE® XR (saxagliptin and metformin hydrochloride extended-release) Tablets
-
LYNPARZA™ (olaparib) Capsules
-
MERREM® I.V. (meropenem for injection)
-
MOVANTIK™ (naloxegol) Tablets
-
MYALEPT™ (metreleptin) for Injection
-
ONGLYZA® (saxagliptin) Tablets
-
SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets
-
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
-
SYMLIN® (pramlintide acetate) Injection
-
Tudorza Pressair® (aclidinium bromide inhalation powder) 400mcg
-
XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) Tablets
-
ZOLADEX® (goserelin acetate implant) 10.8 mg 3-month depot
-
ZOLADEX® (goserelin acetate implant) 3.6 mg 1-month depot
The information provided on this page was provided by AstraZeneca. For full information about specific medicines,including the FDA-approved prescribing information, please visit www.AstraZeneca-us.com.